← Product Code [HWC](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HWC) · K970912 # LEIBINGER SELF-DRILLING SCREW (K970912) _Howmedica Leibinger, Inc. · HWC · Oct 1, 1997 · Orthopedic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HWC/K970912 ## Device Facts - **Applicant:** Howmedica Leibinger, Inc. - **Product Code:** [HWC](/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HWC.md) - **Decision Date:** Oct 1, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 888.3040 - **Device Class:** Class 2 - **Review Panel:** Orthopedic - **Attributes:** Therapeutic ## Intended Use This device is intended for use in internal fixation of small bones including the craniomaxillofacial skeleton and hand secondary to trauma or for reconstruction. ## Device Story Leibinger® Self-Drilling Screw is a metallic bone fixation fastener designed for internal fixation of small bones in the craniomaxillofacial skeleton and hand. The device is available in diameters of 1.2 mm, 1.7 mm, and 2.0 mm, with lengths ranging from 4 mm to 8 mm. The screw features a self-drilling design, allowing for single-step insertion without the need for pre-drilling. It is intended for use by surgeons in clinical settings for trauma repair or reconstructive surgery. The device provides mechanical stabilization of bone fragments, facilitating healing and structural restoration. ## Clinical Evidence No clinical data provided; substantial equivalence is based on design, material, and intended use similarities to legally marketed predicate devices. ## Technological Characteristics Metallic bone fixation fastener manufactured from titanium alloy. Features a self-drilling thread design for single-step insertion. Available in diameters of 1.2 mm, 1.7 mm, and 2.0 mm with lengths between 4 mm and 8 mm. ## Regulatory Identification A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system. ## Predicate Devices - KLS Martin Centre-Drive Drill-Free™ Screw ([K944565](/device/K944565.md)) - Leibinger® Luhr® Small Bone Screws ([K963739](/device/K963739.md)) - Leibinger® Luhr® Small Bone Screws ([K963740](/device/K963740.md)) - Leibinger® Luhr® Small Bone Screws ([K963741](/device/K963741.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} K970912 # 510(k) Summary OCT. 1 1997 Device Proprietary Name: Leibinger® Self-Drilling Screw Device Common Name: Small Bone Screw Classification Name: Smooth or threaded metallic bone fixation fastener 21 CFR 888.3040 Name of Submitter: Howmedica Leibinger Inc. Contact Person: Kristyn R. Waski Quality Assurance/Regulatory Affairs Engineer Howmedica Leibinger Inc. 14540 Beltwood Pkwy., East Dallas, TX 75244 Telephone: (972) 392-3636 x266 Fax: (972) 392-7258 Date Prepared: March 11, 1997 Date Revised: September 29, 1997 ## Summary: This submission describes self drilling bone screws intended for use in internal fixation of small bones including the craniomaxillofacial skeleton and hand, secondary to trauma or for reconstruction. The Self Drilling Screw is available in 1.2 and 1.7 mm diameters with lengths ranging from 4-7 mm and in a 2.0 mm diameter with lengths ranging from 5-8 mm. Equivalence for this device is based on similarities in intended use, material, design and operational principle to the KLS Martin Centre-Drive Drill-Free™ Screw [K944565] and the Leibinger® Luhr® Small Bone Screws [K963739, K963740 and K963741]. Each of the screw systems is intended for use in fixation of small bones secondary to trauma or for reconstruction. The Leibinger® Luhr® Small Bone Screws and the Leibinger® Self Drilling Screws are intended for use in craniomaxillofacial and hand fixation. The KLS Martin Centre-Drive Drill-Free™ Screws and the Leibinger® Self Drilling Screws are both designed as self drilling screws intended for use in internal fixation of the craniomaxillofacial skeleton. Each of the screw systems is manufactured from titanium alloy. The basic operational principle is similar for each of the named screw systems. The Leibinger® Self Drilling and KLS Martin Centre-Drive Drill-Free™ Screws are both self drilling and can be inserted in one step. Indications and contraindications are equivalent for each of the equivalent devices. {1} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 OCT - 1 1997 Ms. Kristyn R. Waski Quality Assurance/Regulatory Affairs Engineer Howmedica Inc. Pfizer Hospital Products Group 14540 Beltwood Parkway East Dallas, Texas 75244 Re: K970912 Trade Name: Leibinger® Self-Drilling Screw Regulatory Class: II Product Code: HWC Dated: July 2, 1997 Received: July 3, 1997 Dear Ms. Waski: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {2} Page 2 - Ms. Kristyn R. Waski This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, ![img-0.jpeg](img-0.jpeg) Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3} 510(k) Number (if known): UNKNOWN AT THIS TIME Device Name: Leibinger® Self Drilling Screw Indications for Use: This device is intended for use in internal fixation of small bones including the craniomaxillofacial skeleton and hand secondary to trauma or for reconstruction. (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) ![img-1.jpeg](img-1.jpeg) Prescription Use ☑ OR Over-The-Counter Use ☐ (Optional Format 1-2-96) --- **Source:** [https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HWC/K970912](https://fda.innolitics.com/submissions/OR/subpart-d%E2%80%94prosthetic-devices/HWC/K970912) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com